The following sections of the instructions for medical use of the drug have been amended;
– “Side Effects.” – The information has been updated. Information was added to subsection: “Skin and subcutaneous tissue disorders”: acute generalized exanthematous pustulosis and drug rash with eosinophilia and systemic symptoms (DRESS syndrome) with an incidence of “very rare”.
